GlaxoSmithKline patient assistance programs provided medicines valued at almost $388 million (Wholesale Acquisition Cost) to more than 484,000 patients during 2007.

Commitment to Access provides free GSK oncology and specialty pharmacy medicines to eligible low-income patients without prescription drug benefits. Commitment to Access also accepts eligible patients with Medicare Part D or generic-only drug benefits. Patients must meet certain eligibility criteria to qualify for assistance and must enroll in Commitment to Access with the help of an Advocate.

All GSK oncology and specialty pharmacy medicines are offered for use in an outpatient setting. GSK non-oncology medicines are available through a separate program, Bridges to Access.

We’ve developed a telephone enrollment process that allows initial eligibility determinations to be made quickly so that patients may promptly obtain their prescribed GSK medicines. See the Enrollment for additional information.